Cataract lens breakthrough? new implant could let you ditch glasses
NCT ID NCT07092020
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new type of lens implant (extended depth of focus IOL) for people with age-related cataracts. The lens is designed to provide clear vision at multiple distances, potentially reducing the need for glasses after surgery. About 220 adults will be randomly assigned to receive either the new lens or a standard monofocal lens, and their vision will be compared over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
extended depth of focus intraocular lens (IOL)
What this could lead to
If it works, this lens could help people see clearly at near, intermediate, and far distances after cataract surgery, reducing dependence on glasses.
What could go wrong
This is a relatively small trial (220 people) comparing a new lens to a standard one. The new lens may not provide better vision or could cause more visual disturbances like glare.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATARACT SENILE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Eye Hospital Zora
RECRUITINGSofia, Bulgaria
Contact
-
Hospital Universitario Ramón y Cajal
RECRUITINGMadrid, Spain
Contact
-
Medical Center "Vereya"
RECRUITINGStara Zagora, Bulgaria
Contact
-
Medoptic Clinic
ACTIVE_NOT_RECRUITINGSuceava, Romania
-
Nemocnice Havlíčkův
RECRUITINGHavlíčkův Brod, Czechia
Contact
-
OFTEX ocni
RECRUITINGPardubice, Czechia
Contact
-
OMIQ Hospital Universitari
ACTIVE_NOT_RECRUITINGSant Cugat del Vallès, Spain
-
Oculus Eye Clinic
ACTIVE_NOT_RECRUITINGBucharest, Romania
-
Ofta Total Clinic
ACTIVE_NOT_RECRUITINGSibiu, Romania
-
Oftalvist
RECRUITINGAlicante, Spain
Contact
-
Oftalvist
RECRUITINGValencia, Spain
Contact
-
Oční Centrum
RECRUITINGPrague, Czechia
Contact
-
Specialized Ophthalmological Hospital for Active Treatment
RECRUITINGSofia, Bulgaria
Contact
-
University Hopital Complex of Santiago de Compostela
ACTIVE_NOT_RECRUITINGSantiago de Compostela, Spain